MARSHALL WACE, LLP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$376,769
-72.9%
133,134
+107.7%
0.00%
-83.3%
Q1 2021$1,392,000
+603.0%
64,099
+312.4%
0.01%
+500.0%
Q3 2020$198,000
-83.0%
15,543
-77.2%
0.00%
-87.5%
Q2 2020$1,164,000
-72.9%
68,023
-79.4%
0.01%
-81.8%
Q4 2018$4,290,000
-80.1%
330,022
-63.4%
0.04%
-52.2%
Q3 2018$21,570,000
+222.8%
900,648
+158.1%
0.09%
-8.0%
Q2 2018$6,682,000348,9260.10%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,568,057$70,005,00074.08%
Chescapmanager LLC 1,203,055$23,604,0002.80%
Mesirow Financial Investment Management, Inc. 29,821$585,0002.32%
DAFNA Capital Management LLC 143,611$2,818,0001.22%
Opaleye Management Inc. 200,000$3,924,0001.09%
SPHERA FUNDS MANAGEMENT LTD. 303,930$5,963,0000.54%
DISCIPLINED GROWTH INVESTORS INC /MN 852,892$16,734,0000.29%
DLD Asset Management, LP 352,700$6,927,0000.26%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 54,984$1,079,0000.18%
B. Riley Wealth Management, Inc. 33,755$662,0000.12%
View complete list of CARA THERAPEUTICS INC shareholders